[Cytostatic drugs in the therapy of psoriasis].
D000477:Alkylating Agents / Q000627:therapeutic use; D000630:Aminopterin / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011033:Podophyllin / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D011687:Purines / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000037:antagonists & inhibitors; D012867:Skin / Q000201:enzymology / Q000378:metabolism; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D011687:Purines; D011743:Pyrimidines; D014750:Vincristine; D014747:Vinblastine; D011033:Podophyllin; D000630:Aminopterin; D006918:Hydroxyurea; D008727:Methotrexate
I farmaci citostatici nella terapia della psoriasi.